Kamkari Nick A, Osadchiy Vadim, Wood Erika L, Williams Kristen C, Piqueiras Eduardo, Donin Nicholas M
Department of Urology, University of Massachusetts Chan Medical School, Worcester, MA, USA.
Department of Urology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA.
Transl Androl Urol. 2025 Apr 30;14(4):1129-1137. doi: 10.21037/tau-2025-41. Epub 2025 Apr 27.
Penile cancer (PeCa) is a rare urologic malignancy in the United States, and public awareness remains low. In this brief report, we design and execute a survey to evaluate knowledge and awareness of PeCa focusing on general PeCa knowledge, treatment options, and willingness to recommend a preventative intervention. Study participants were recruited with a study flyer from the waiting room of two Los Angeles community-based urology clinics. All patients were English-speaking and over 18 years old. Study recruitment took place from October 2021 to June 2022 and 83 participants were included. The majority of respondents were men (90%) and white (87%), with a mean age 63 years. Ninety-eight percent of respondents reported either knowing "nothing" or "a little" about PeCa; 69% of respondents did not know a person could get cancer on the penis. Knowledge of risk factors for PeCa was particularly poor, with respect to phimosis (5% correctly identified this as a risk factor), balanitis (28%), and human papilloma virus (HPV) (44%). The majority of respondents, however, reported that they would recommend administration of an HPV vaccine for the prevention of PeCa (89%) once informed of HPV as a risk factor. Our findings underscore the lack of knowledge and awareness of PeCa, which may contribute to future delays in care.
阴茎癌（PeCa）在美国是一种罕见的泌尿系统恶性肿瘤，公众认知度仍然较低。在本简要报告中，我们设计并开展了一项调查，以评估对阴茎癌的知识和认知，重点关注阴茎癌的一般知识、治疗选择以及推荐预防性干预措施的意愿。研究参与者是通过在洛杉矶两家社区泌尿外科诊所的候诊室发放研究传单招募的。所有患者均为英语使用者且年龄超过18岁。研究招募于2021年10月至2022年6月进行，共纳入83名参与者。大多数受访者为男性（90%）且为白人（87%），平均年龄63岁。98%的受访者表示对阴茎癌“一无所知”或“了解一点”；69%的受访者不知道人会患阴茎癌。对阴茎癌危险因素的了解尤其匮乏，关于包茎（5%正确将其识别为危险因素）、龟头炎（28%）和人乳头瘤病毒（HPV）（44%）。然而，大多数受访者表示，一旦得知HPV是危险因素，他们会推荐接种HPV疫苗来预防阴茎癌（89%）。我们的研究结果强调了对阴茎癌缺乏知识和认知，这可能导致未来的治疗延误。
